GTG.AX - Genetic Technologies Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2019
30/06/2018
30/06/2017
30/06/2016
Total revenue
110
25
189
519
825
Cost of revenue
226
276
300
492
743
Gross profit
-116
-251
-111
26
82
Operating expenses
Research development
2,556
2,361
2,210
2,366
2,585
Selling general and administrative
3,977
4,406
4,082
5,831
6,719
Total operating expenses
6,112
5,910
5,866
7,944
8,644
Operating income or loss
-6,228
-6,161
-5,977
-7,918
-8,562
Interest expense
-
20
29
32
29
Total other income/expenses net
949
-270
527
-493
65
Income before tax
-5,288
-6,426
-5,464
-8,404
-8,459
Income tax expense
0
0
0
0
0
Income from continuing operations
-5,288
-6,426
-5,464
-8,404
-8,459
Net income
-5,288
-6,426
-5,464
-8,404
-8,459
Net income available to common shareholders
-5,288
-6,426
-5,464
-8,404
-8,459
Reported EPS
Basic
-
-
-0.00
-0.00
-0.00
Diluted
-
-
-0.00
-0.00
-0.00
Weighted average shares outstanding
Basic
-
-
2,609,233
2,273,185
1,837,730
Diluted
-
-
2,609,233
2,273,185
1,837,730
EBITDA
-
-6,406
-5,435
-8,372
-8,430